Basit öğe kaydını göster

dc.contributor.authorAltintas, Faik
dc.contributor.authorGurbuz, Hakan
dc.contributor.authorErdemli, Buelent
dc.contributor.authorAtilla, Buelent
dc.contributor.authorUstaoglu, Recep Guer
dc.contributor.authorOzic, Ugur
dc.contributor.authorKinik, Hakan
dc.date.accessioned2020-06-21T15:12:50Z
dc.date.available2020-06-21T15:12:50Z
dc.date.issued2008
dc.identifier.issn1017-995X
dc.identifier.urihttps://doi.org/10.3944/AOTT.2008.322
dc.identifier.urihttps://hdl.handle.net/20.500.12712/19111
dc.descriptionKINIK, HUSEYIN HAKAN/0000-0003-4768-8415; Erdemli, Bulent/0000-0003-3403-5140; ATILLA, BULENT/0000-0003-4796-0642en_US
dc.descriptionWOS: 000262566100005en_US
dc.descriptionPubMed: 19158452en_US
dc.description.abstractObjectives: We investigated risk factors for venous thromboembolism (VTE), prophylaxis measures employed, and incidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopaedic surgery (MOS). Methods: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these. 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients. Results: Risk factors for VTE were seen in 73.2% of the patents. the most common being obesity (72%) and prolonged immobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compression stockings in 610 patients (67.9%) and by intermittent pneumatic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively. Conclusion: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS.en_US
dc.language.isoturen_US
dc.publisherTurkish Assoc Orthopaedics Traumatologyen_US
dc.relation.isversionof10.3944/AOTT.2008.322en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticoagulants/therapeutic useen_US
dc.subjectarthroplasty, replacement, hipen_US
dc.subjectarthroplasty, replacement, kneeen_US
dc.subjectpostoperative complicationsen_US
dc.subjectrisk factorsen_US
dc.subjectthromboembolismen_US
dc.subjectvenous thrombosisen_US
dc.titleVenous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational studyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume42en_US
dc.identifier.issue5en_US
dc.identifier.startpage322en_US
dc.identifier.endpage327en_US
dc.relation.journalActa Orthopaedica Et Traumatologica Turcicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster